Bianca Pourmussa
Overview
Explore the profile of Bianca Pourmussa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gan S, Azzo J, Zhao L, Pourmussa B, Dib M, Salman O, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e011728.
PMID: 39831311
Background: Iron deficiency (ID) is currently defined as a serum ferritin level <100 or 100 to 299 ng/mL with transferrin saturation (TSAT) <20%. Serum ferritin and TSAT are currently used...
2.
Zamani P, Shah S, Cohen J, Zhao M, Yang W, Afable J, et al.
JAMA Cardiol
. 2024 Dec;
10(3):284-289.
PMID: 39693096
Importance: Nitric oxide deficiency may contribute to exercise intolerance in patients with heart failure with preserved ejection fraction (HFpEF). Prior pilot studies have shown improvements in exercise tolerance with single-dose...
3.
Dib M, Azzo J, Zhao L, Salman O, Gan S, De Buyzere M, et al.
JACC Basic Transl Sci
. 2024 Nov;
9(10):1178-1191.
PMID: 39534640
The molecular mechanisms contributing to large artery stiffness (LAS) are not fully understood. The aim of this study was to investigate the association between circulating plasma proteins and LAS using...
4.
Salman O, Zhao L, Cohen J, Dib M, Azzo J, Gan S, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e033660.
PMID: 39206761
Background: Kidney disease is common in heart failure with preserved ejection fraction (HFpEF). However, the biologic correlates and prognostic significance of kidney injury (KI), in HFpEF, beyond the estimated glomerular...
5.
Salman O, Zamani P, Zhao L, Dib M, Gan S, Azzo J, et al.
J Am Heart Assoc
. 2024 Aug;
13(17):e033675.
PMID: 39206715
Background: The role of cellular senescence in human heart failure (HF) remains unclear. The senescence-associated secretory phenotype (SASP) is composed of proteins released by senescent cells. We assessed the prognostic...
6.
Tada A, Burkhoff D, Naser J, Harada T, Pourmussa B, Reddy Y, et al.
Circulation
. 2024 Aug;
150(13):997-1009.
PMID: 39101201
Background: Systemic arterial compliance and venous capacitance are typically impaired in patients with heart failure with preserved ejection fraction (HFpEF), contributing to hemodynamic congestion with stress. Sodium-glucose cotransporter-2 inhibitors reduce...
7.
Chirinos J, Lopez-Jaramillo P, Giamarellos-Bourboulis E, Davila-Del-Carpio G, Bizri A, Andrade-Villanueva J, et al.
Nat Metab
. 2022 Nov;
4(12):1847-1857.
PMID: 36344766
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cytotoxicity may involve inhibition of peroxisome proliferator-activated receptor alpha. Fenofibrate activates peroxisome proliferator-activated receptor alpha and inhibits SARS-CoV-2 replication in vitro. Whether fenofibrate...
8.
Chirinos J, Lopez-Jaramillo P, Giamarellos-Bourboulis E, Davila-Del-Carpio G, Bizri A, Andrade-Villanueva J, et al.
Res Sq
. 2022 Aug;
PMID: 35982675
Background Abnormal cellular lipid metabolism appears to underlie SARS-CoV-2 cytotoxicity and may involve inhibition of peroxisome proliferator activated receptor alpha (PPARα). Fenofibrate, a PPAR-α activator, modulates cellular lipid metabolism. Fenofibric...
9.
Vidula M, Orlenko A, Zhao L, Salvador L, Small A, Horton E, et al.
Eur J Heart Fail
. 2021 Oct;
23(12):2021-2032.
PMID: 34632675
Aims: Enhanced risk stratification of patients with aortic stenosis (AS) is necessary to identify patients at high risk for adverse outcomes, and may allow for better management of patient subgroups...